Publications by authors named "Masuzu Ueda"

Claim this Profile
I
Impact of Real-World Clinical Factors on an Analysis of the Cost-Effectiveness of "Immediate CAR-T" Versus "Late CAR-T" as Second-Line Treatment for DLBCL Patients.
Chihiro Yamamoto, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Shuka Furuki, Masuzu Ueda

Transplant Cell Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
Daisuke Minakata, Shin-Ichiro Fujiwara, Seina Honda, Ryutaro Tominaga, Daizo Yokoyama, Masuzu Ueda

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma.
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Masuzu Ueda

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, Kaoru Sekiguchi, Yuta Fukui, Masuzu Ueda

Blood· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma.
Kaoru Hatano, Shin-Ichiro Fujiwara, Kento Umino, Takashi Ikeda, Hirofumi Nakano, Masuzu Ueda

Ann Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation.
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Masuzu Ueda

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice.
Hiroshi Okabe, Takahiro Suzuki, Eisuke Uehara, Masuzu Ueda, Tadashi Nagai

Eur J Haematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
Akiko Meguro, Katsutoshi Ozaki, Kazuya Sato, Iekuni Oh, Shinichiro Fujiwara, Masuzu Ueda

Leuk Lymphoma· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal failure caused by plasma cell infiltration in multiple myeloma.
Shiho Hanawa, Tetsu Akimoto, Eisuke Uehara, Makoto Inoue, Toshimi Imai, Masuzu Ueda

Clin Exp Nephrol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of response and survival following chemotherapy treatment in acute myeloid leukemia progression from myelodysplastic syndrome.
Hiroyuki Kobayashi, Tomohiro Matsuyama, Masuzu Ueda, Takahiro Suzuki, Katsutoshi Ozaki

Intern Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic recovery after administration of deferasirox for transfusional iron overload in a case of myelodysplastic syndrome.
Hiroshi OKABE, Takahiro SUZUKI, Tsukasa OMORI, Masaki MORI, Eisuke UEHARA, Masuzu UEDA

Rinsho Ketsueki· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia.
Satoko Oka, Kazuo Muroi, Tomohiro Matsuyama, Kazuya Sato, Masuzu Ueda

Hematology· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes.
Satoko Oka, Kazuo Muroi, Masaki Mori, Tomohiro Matsuyama, Shin-ichiro Fujiwara, Masuzu Ueda

Leuk Lymphoma· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.
Satoko Oka, Kazuo Muroi, Masaki Mori, Tomohiro Matsuyama, Sin-ichiro Fujiwara, Masuzu Ueda

Intern Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Benefits of mycophenolate mofetil for refractory graft-versus-host disease].
Masaki Mori, Kazuo Muroi, Tomohiro Matsuyama, Satoko Oka, Yoko Ono, Masuzu Ueda

Rinsho Ketsueki· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Saburo Tsunoda, Hiroyuki Kobayashi, Koichi Inoue, Tohru Izumi, Miyuki Akutsu, Tomoki Ueda, Masuzu Ueda

Gan To Kagaku Ryoho· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia.
Chizuko Tsutsumi, Masuzu Ueda, Yasushi Miyazaki, Yoshihiro Yamashita, Young Lim Choi

Exp Hematol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome.
Masuzu Ueda, Jun Ota, Yoshihiro Yamashita, Young Lim Choi, Ruri Ohki

Br J Haematol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New human myelodysplastic cell line, TER-3: G-CSF specific downregulation of Ca2+/calmodulin-dependent protein kinase IV.
Yuji Mishima, Yasuhito Terui, Yuko Mishima, Misa Katsuyama, Masaki Mori, Masuzu Ueda

J Cell Physiol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis